EG 427 announces attendance to multiple upcoming conferences in fall 2023

September 26, 2023

EG 427 announces participation to 3 upcoming conferences in October and November 2023.

  • East-West Biopharma Summit, Boston, MA, October 2-4, 2023
  • BioFuture, New York, NY, October 4-6, 2023 
  • BIO-Europe, Munich, Germany, November 6-8, 2023

To request a one-on-one meeting with our delegates, please contact us.

Please read the full Press release for more details.


Recent posts

EG 427 Appoints Don Haut, Ph.D as Chief Business Officer and Opens US Headquarters
EG 427 Appoints Don Haut, Ph.D as Chief Business Officer and Opens US Headquarters

read more >

EG 427 Announces Positive Preclinical Results from EG110A IND-Enabling Study in Neurogenic Detrusor Overactivity and Overactive Bladder
EG 427 Announces Positive Preclinical Results from EG110A IND-Enabling Study in Neurogenic Detrusor Overactivity and Overactive Bladder

read more >

EG 427 to hold poster presentation on lead asset EG110A at ESGCT
EG 427 to hold poster presentation on lead asset EG110A at ESGCT

read more >

EG 427 presents positive preclinical data on lead asset EG110A at International Continence Society meeting
EG 427 presents positive preclinical data on lead asset EG110A at International Continence Society meeting

read more >

EG 427 announces final Series A closing, achieving €18 million in total funds raised
EG 427 announces final Series A closing, achieving €18 million in total funds raised

read more >

×

Essential Cookies

These cookies are necessary for the website to function and cannot be turned off. They are used, for example, to maintain the contents of the user's basket. You can set your browser to block these cookies, but then the website will not function prope

Always active

Analytical cookies

These cookies allow you to count visits and traffic sources. Thanks to these files, it is known which pages are more popular and how the website visitors navigate. All information these cookies collect is anonymous.